Total Payments
$264,271
2024 Payments
$36,018
Companies
13
Transactions
320
Medicare Patients
2,305
Medicare Billing
$268,458
Payment Breakdown by Category
Other$209,030 (79.1%)
Travel$29,526 (11.2%)
Consulting$19,946 (7.5%)
Food & Beverage$5,697 (2.2%)
Education$71.90 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $167,330 | 89 | 63.3% |
| Honoraria | $41,700 | 19 | 15.8% |
| Travel and Lodging | $29,526 | 109 | 11.2% |
| Consulting Fee | $19,946 | 10 | 7.5% |
| Food and Beverage | $5,697 | 91 | 2.2% |
| Education | $71.90 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $81,749 | 120 | $0 (2020) |
| SK Life Science, Inc. | $48,589 | 63 | $0 (2024) |
| Neurelis, Inc. | $39,913 | 41 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $33,584 | 24 | $0 (2024) |
| Greenwich Biosciences, Inc. | $26,779 | 32 | $0 (2021) |
| Eisai Inc. | $20,550 | 21 | $0 (2020) |
| UCB, Inc. | $7,643 | 11 | $0 (2024) |
| Monteris Medical Corporation | $4,200 | 3 | $0 (2021) |
| Biogen, Inc. | $568.45 | 1 | $0 (2018) |
| LivaNova USA, Inc. | $400.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,018 | 34 | JAZZ PHARMACEUTICALS INC. ($15,378) |
| 2023 | $41,947 | 48 | SK Life Science, Inc. ($14,481) |
| 2022 | $16,971 | 19 | SK Life Science, Inc. ($10,471) |
| 2021 | $20,932 | 19 | SK Life Science, Inc. ($12,140) |
| 2020 | $31,023 | 35 | SK Life Science, Inc. ($10,786) |
| 2019 | $36,478 | 44 | Greenwich Biosciences, Inc. ($22,045) |
| 2018 | $29,093 | 45 | Sunovion Pharmaceuticals Inc. ($26,007) |
| 2017 | $51,808 | 76 | Sunovion Pharmaceuticals Inc. ($43,526) |
All Payment Transactions
320 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $98.25 | General |
| 11/07/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,036.00 | General |
| Category: EPILEPSY | ||||||
| 11/07/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,036.00 | General |
| Category: EPILEPSY | ||||||
| 11/07/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,036.00 | General |
| Category: EPILEPSY | ||||||
| 10/29/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | In-kind items and services | $933.47 | General |
| Category: EPILEPSY | ||||||
| 10/29/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | In-kind items and services | $904.50 | General |
| Category: EPILEPSY | ||||||
| 10/29/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | In-kind items and services | $176.89 | General |
| Category: EPILEPSY | ||||||
| 10/29/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $105.31 | General |
| Category: EPILEPSY | ||||||
| 10/29/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: EPILEPSY | ||||||
| 10/28/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | In-kind items and services | $931.25 | General |
| Category: EPILEPSY | ||||||
| 10/28/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $104.15 | General |
| Category: EPILEPSY | ||||||
| 10/22/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Travel and Lodging | In-kind items and services | $69.68 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,540.00 | General |
| Category: NEUROLOGY | ||||||
| 10/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROLOGY | ||||||
| 05/20/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,130.00 | General |
| Category: NEUROLOGY | ||||||
| 05/15/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $125.07 | General |
| Category: NEUROLOGY | ||||||
| 05/11/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $135.53 | General |
| 03/22/2024 | UCB, Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $5,120.00 | General |
| Category: Neurology | ||||||
| 03/22/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $575.00 | General |
| Category: Neurology | ||||||
| 03/22/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | Cash or cash equivalent | $115.33 | General |
| Category: Neurology | ||||||
| 03/22/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | Cash or cash equivalent | $44.38 | General |
| Category: Neurology | ||||||
| 03/16/2024 | UCB, Inc. | Fintepla (Drug) | Travel and Lodging | In-kind items and services | $231.74 | General |
| Category: Neurology | ||||||
| 03/16/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $67.34 | General |
| Category: Neurology | ||||||
| 03/16/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $64.78 | General |
| Category: Neurology | ||||||
| 03/16/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $49.60 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 592 | 725 | $475,969 | $73,821 |
| 2022 | 12 | 605 | 710 | $409,099 | $67,085 |
| 2021 | 11 | 594 | 719 | $423,097 | $68,620 |
| 2020 | 9 | 514 | 622 | $360,180 | $58,932 |
Total Patients
2,305
Total Services
2,776
Medicare Billing
$268,458
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 117 | 240 | $275,040 | $41,583 | 15.1% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 78 | 78 | $57,720 | $8,639 | 15.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 97 | 98 | $31,547 | $4,403 | 14.0% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2023 | 35 | 35 | $22,645 | $3,424 | 15.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 36 | $11,628 | $3,395 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 21 | $9,114 | $2,584 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $11,734 | $2,418 | 20.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 51 | 53 | $16,483 | $2,395 | 14.5% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2023 | 61 | 61 | $14,945 | $2,246 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 32 | $7,008 | $1,923 | 27.4% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Facility | 2023 | 50 | 51 | $18,105 | $811.67 | 4.5% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 82 | 165 | $189,090 | $29,411 | 15.6% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 62 | 65 | $48,100 | $7,519 | 15.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 117 | 118 | $39,905 | $5,711 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 70 | $22,610 | $5,375 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 35 | $15,190 | $5,007 | 33.0% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2022 | 41 | 41 | $26,527 | $4,143 | 15.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 64 | 64 | $19,904 | $2,994 | 15.0% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2022 | 63 | 63 | $15,435 | $2,440 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $9,284 | $1,712 | 18.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 13 | $3,250 | $1,332 | 41.0% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Facility | 2022 | 44 | 49 | $17,395 | $815.88 | 4.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $2,409 | $626.79 | 26.0% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 92 | 190 | $217,740 | $33,761 | 15.5% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 60 | 64 | $47,360 | $7,449 | 15.7% |
About Dr. Stephan Schuele, MD
Dr. Stephan Schuele, MD is a Neurology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427047000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephan Schuele, MD has received a total of $264,271 in payments from pharmaceutical and medical device companies, with $36,018 received in 2024. These payments were reported across 320 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($167,330).
As a Medicare-enrolled provider, Schuele has provided services to 2,305 Medicare beneficiaries, totaling 2,776 services with total Medicare billing of $268,458. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology, Epilepsy
- Location Chicago, IL
- Active Since 10/17/2005
- Last Updated 08/05/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1427047000
Products in Payments
- APTIOM (Drug) $81,626
- XCOPRI (Drug) $43,126
- VALTOCO (Drug) $39,913
- EPIDIOLEX (Drug) $33,584
- Epidiolex (Drug) $26,779
- Fycompa (Drug) $15,750
- Fintepla (Drug) $7,545
- Cenobamate (Drug) $5,159
- Dayvigo (Drug) $4,800
- Neuroblate (Device) $4,200
- VNS - Sentiva (Device) $400.00
- SABRIL (Drug) $125.00
- TROKENDI XR (Drug) $14.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Chicago
Mr. Augusto Miravalle, Md, MD
Neurology — Payments: $1.1M
Neurology $1.1M
Adil Javed
Neurology — Payments: $1.0M
Neurology $1.0M
Douglas Nordli, Md, MD
Neurology — Payments: $654,190
Neurology $654,190
Dr. Dusan Stefoski, Md, MD
Neurology — Payments: $610,165
Neurology $610,165
Dr. Danny Bega, M.d, M.D
Neurology — Payments: $432,383
Neurology $432,383
Tatyana Simuni, Md, MD
Neurology — Payments: $385,696
Neurology $385,696